Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression
AssigneeSupernus Pharmaceuticals, Inc.
InventorsJennifer DUGAN STOCKS, Christopher EVANS, Seung HWANG, Susan M. DALLABRIDA
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to the treatment of impulsive aggression with molindone as an add-on therapy where patients are already receiving treatment for the underlying disease or disorder, e.g. attention deficit hyperactivity disorder (ADHD), bipolar disorder, autism, Tourette's syndrome or post traumatic stress disorder (PTSD), using evidence-based impulsive aggression testing methodologies and systems.
Claims29
A method of treating a patient having impulsive aggression (IA) by administering an impulsive aggression intervention, comprising:
- (a) monitoring the patient for one or more aggressive episodes by:
- providing the patient or a caregiver of the patient with a questionnaire to determine a pre-intervention baseline cumulative score of the patient,
- initiating an impulsive aggression intervention treatment, and
- providing the patient or the caregiver with the questionnaire to determine a post-intervention cumulative score of the patient;
- and either
- (b) continuing to administer the impulsive aggression intervention treatment if the post-intervention cumulative score is lower than the pre-intervention baseline cumulative score;
- or
- (c) varying the impulsive aggression intervention treatment if the post-intervention cumulative score is not lower than the pre-intervention baseline cumulative score.
2-7. (canceled)
29-94. (canceled)
Dependencies are inferred from the claim text.